- Report
- February 2025
- 200 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- August 2025
- 188 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- September 2025
- 510 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- June 2025
- 400 Pages
Global
From €4322EUR$4,949USD£3,755GBP
- Report
- October 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- January 2025
- 175 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- August 2025
- 198 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 197 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- April 2025
- 175 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- February 2025
- 182 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- February 2025
- 183 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- September 2025
- 436 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- June 2025
- 130 Pages
Global
From €3600EUR$4,123USD£3,128GBP
€4236EUR$4,850USD£3,680GBP
- Report
- June 2022
- 225 Pages
Global
From €4323EUR$4,950USD£3,755GBP
- Report
- August 2024
- 140 Pages
Global
From €2619EUR$2,999USD£2,275GBP
- Report
- May 2023
- 110 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- July 2024
- 158 Pages
Global
From €2183EUR$2,500USD£1,897GBP
- Report
- March 2024
- 200 Pages
Global
From €3624EUR$4,150USD£3,148GBP
- Report
- July 2024
- 100 Pages
Global
From €3275EUR$3,750USD£2,845GBP
- Report
- July 2024
- 100 Pages
Global
From €3275EUR$3,750USD£2,845GBP

The Nerve Repair market within the context of Genomics is focused on the development of treatments and therapies that can help to repair damaged nerves. This includes the use of gene therapy, stem cell therapy, and other regenerative medicine approaches. Genomics has enabled researchers to better understand the genetic basis of nerve damage and to develop treatments that can target specific genetic pathways. In addition, genomics has enabled the development of personalized treatments that can be tailored to the individual patient.
Companies in the Nerve Repair market include AxoGen, Inc., BioTime, Inc., BrainStorm Cell Therapeutics, Inc., and Neuralstem, Inc. Show Less Read more